Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 7/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 7/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.35 |
| ▸ | HTR2A | P28223 | 2/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.33 |
| ▸ | EGFR | P00533 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13818263 | 0.90 | CHRM1 (0.45) | CHRM1CHRM5CHRM3DRD2KCNH2 | |
| SCHEMBL13692826 | 0.84 | CHRM1 (0.44) | CHRM1CHRM5CHRM3DRD2KCNH2 | |
| SCHEMBL15617903 | 0.76 | CHRM1 (0.46) | CHRM1CHRM5CHRM3DRD2KCNH2 | |
| SCHEMBL4101713 | 0.74 | CHRM1 (0.48) | CHRM1CHRM5CHRM3DRD2KCNH2 | |
| SCHEMBL13818265 | 0.74 | CHRM1 (0.48) | CHRM1CHRM5CHRM3DRD2KCNH2 | |
| SCHEMBL4098902 | 0.73 | CHRM1 (0.44) | CHRM1CHRM5CHRM3DRD2KCNH2 | |
| SCHEMBL4090325 | 0.69 | CHRM1 (0.49) | CHRM1CHRM5CHRM3DRD2KCNH2 | |
| SCHEMBL4054963 | 0.68 | CHRM1 (0.54) | CHRM1CHRM5CHRM3DRD2HTR2A | |
| SCHEMBL4089822 | 0.66 | CHRM1 (0.60) | CHRM1CHRM5CHRM3DRD2KCNH2 | |
| SCHEMBL29901598 | 0.66 | CHRM1 (0.46) | CHRM1CHRM5CHRM3EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7550459-B2 | Neurodegenerative diseases, psychological disorders; e.g. 4-[3-(3a -Cyclopropylmethoxy-8-azabicyclo[3.2.1]oct-8-yl)-2-methylpropyl]-4H-benzo[1.4]oxazin-3-one | ACADIA PHARMACEUTICALS, INC. (US) | 2009-06-23 | — | — | US | disclosed |
| US-7550459-B2 | Neurodegenerative diseases, psychological disorders; e.g. 4-[3-(3a -Cyclopropylmethoxy-8-azabicyclo[3.2.1]oct-8-yl)-2-methylpropyl]-4H-benzo[1.4]oxazin-3-one | ACADIA PHARMACEUTICALS, INC. (US) | 2009-06-23 | — | — | US | disclosed |